{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:59:33Z","timestamp":1788400773165,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00508-023-02196-2","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T11:01:53Z","timestamp":1682593313000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study"],"prefix":"10.1007","volume":"136","author":[{"given":"Georg","family":"Semmler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Balcar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Rosenstatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7838-4532","authenticated-orcid":false,"given":"Christian","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"2196_CR1","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","volume":"50","author":"W Jonas","year":"2021","unstructured":"Jonas\u00a0W, Sch\u00fcrmann\u00a0A. Genetic and epigenetic factors determining NAFLD risk. Mol Metab. 2021;50:101111.","journal-title":"Mol Metab"},{"issue":"3","key":"2196_CR2","doi-asserted-by":"publisher","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","volume":"7","author":"EK Speliotes","year":"2011","unstructured":"Speliotes\u00a0EK, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7(3):e1001324.","journal-title":"PLoS Genet"},{"issue":"1","key":"2196_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.dld.2021.06.015","volume":"54","author":"L Balcar","year":"2022","unstructured":"Balcar\u00a0L, et\u00a0al. PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a\u00a0tertiary center. Dig Liver Dis. 2022;54(1):84\u201390.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"2196_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.31032","volume":"71","author":"A Unalp-Arida","year":"2020","unstructured":"Unalp-Arida\u00a0A, Ruhl\u00a0CE. Patatin-like phospholipase domain-containing protein 3 I148M and liver fat and fibrosis scores predict liver disease mortality in the U.S. population. Hepatology. 2020;71(3):820\u201334.","journal-title":"Hepatology"},{"issue":"12","key":"2196_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","volume":"378","author":"NS Abul-Husn","year":"2018","unstructured":"Abul-Husn\u00a0NS, et al. A protein-truncating HSD17B13 variant and protection from chronic liver disease. N\u00a0Engl J Med. 2018;378(12):1096\u2013106.","journal-title":"N Engl J Med"},{"key":"2196_CR6","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1038\/ncomms5309","volume":"5","author":"YL Liu","year":"2014","unstructured":"Liu\u00a0YL, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:4309.","journal-title":"Nat Commun"},{"issue":"5","key":"2196_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina\u00a0RM, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology. 2016;150(5):1219\u20131230e6.","journal-title":"Gastroenterology"},{"issue":"6","key":"2196_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","volume":"68","author":"P Strnad","year":"2019","unstructured":"Strnad\u00a0P, et al. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut. 2019;68(6):1099\u2013107.","journal-title":"Gut"},{"issue":"4","key":"2196_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng.2926","volume":"46","author":"OL Holmen","year":"2014","unstructured":"Holmen\u00a0OL, et\u00a0al. Systematic evaluation of coding variation identifies a\u00a0candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat Genet. 2014;46(4):345\u201351.","journal-title":"Nat Genet"},{"issue":"4","key":"2196_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.gastro.2015.01.038","volume":"148","author":"B Kahali","year":"2015","unstructured":"Kahali\u00a0B, et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology. 2015;148(4):679\u201384.","journal-title":"Gastroenterology"},{"issue":"2","key":"2196_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/hep.27490","volume":"61","author":"P Dongiovanni","year":"2015","unstructured":"Dongiovanni\u00a0P, et\u00a0al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology. 2015;61(2):506\u201314.","journal-title":"Hepatology"},{"issue":"12","key":"2196_CR12","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/ng.3977","volume":"49","author":"DJ Liu","year":"2017","unstructured":"Liu\u00a0DJ, et al. Exome-wide association study of plasma lipids in \u3009300,000\u00a0individuals. Nat Genet. 2017;49(12):1758\u201366.","journal-title":"Nat Genet"},{"issue":"4","key":"2196_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2016.12.020","volume":"152","author":"N Simons","year":"2017","unstructured":"Simons\u00a0N, et\u00a0al. PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease. Gastroenterology. 2017;152(4):912\u20133.","journal-title":"Gastroenterology"},{"issue":"1","key":"2196_CR14","doi-asserted-by":"publisher","first-page":"17785","DOI":"10.1038\/s41598-021-97163-0","volume":"11","author":"S Wernly","year":"2021","unstructured":"Wernly\u00a0S, et al. A sex-specific propensity-adjusted analysis of colonic adenoma detection rates in a\u00a0screening cohort. Sci Rep. 2021;11(1):17785.","journal-title":"Sci Rep"},{"issue":"12","key":"2196_CR15","doi-asserted-by":"publisher","first-page":"e0244514","DOI":"10.1371\/journal.pone.0244514","volume":"15","author":"G Semmler","year":"2020","unstructured":"Semmler\u00a0G, et al. Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease. PLoS ONE. 2020;15(12):e244514.","journal-title":"PLoS ONE"},{"key":"2196_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","author":"M Eslam","year":"2020","unstructured":"Eslam\u00a0M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J\u00a0Hepatol. 2020; https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039.","journal-title":"J Hepatol"},{"issue":"18","key":"2196_CR17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson\u00a0PW, et\u00a0al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837\u201347.","journal-title":"Circulation"},{"issue":"25","key":"2196_CR18","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"group, S.w.","year":"2021","unstructured":"group, S.w., E.C.r. collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart\u00a0J. 2021;42(25):2439\u201354.","journal-title":"Eur Heart J"},{"key":"2196_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12881-014-0112-7","volume":"15","author":"L Kedenko","year":"2014","unstructured":"Kedenko\u00a0L, et\u00a0al. Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort. BMC Med Genet. 2014;15:112.","journal-title":"BMC Med Genet"},{"issue":"4","key":"2196_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwn359","volume":"169","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez\u00a0S, Gaunt\u00a0TR, Day\u00a0IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169(4):505\u201314.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2196_CR21","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2020.01.053","volume":"158","author":"M Krawczyk","year":"2020","unstructured":"Krawczyk\u00a0M, Liebe\u00a0R, Lammert\u00a0F. Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond. Gastroenterology. 2020;158(7):1865\u20131880.e1.","journal-title":"Gastroenterology"},{"issue":"7","key":"2196_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/hep4.1183","volume":"2","author":"S R\u00fcschenbaum","year":"2018","unstructured":"R\u00fcschenbaum\u00a0S, et al. Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events. Hepatol Commun. 2018;2(7):798\u2013806.","journal-title":"Hepatol Commun"},{"issue":"10","key":"2196_CR23","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/jgh.15045","volume":"35","author":"K Wijarnpreecha","year":"2020","unstructured":"Wijarnpreecha\u00a0K, et\u00a0al. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. J\u00a0Gastroenterol Hepatol. 2020;35(10):1789\u201394.","journal-title":"J Gastroenterol Hepatol"},{"issue":"19","key":"2196_CR24","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1073\/pnas.1901974116","volume":"116","author":"S BasuRay","year":"2019","unstructured":"BasuRay\u00a0S, et\u00a0al. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis. Proc Natl Acad Sci USA. 2019;116(19):9521\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2196_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"76","author":"E Scorletti","year":"2022","unstructured":"Scorletti\u00a0E, Carr\u00a0RM. A new perspective on NAFLD: focusing on lipid droplets. J\u00a0Hepatol. 2022;76(4):934\u201345.","journal-title":"J Hepatol"},{"issue":"3","key":"2196_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/hep4.1822","volume":"6","author":"F Luo","year":"2022","unstructured":"Luo\u00a0F, Oldoni\u00a0F, Das\u00a0A. TM6SF2: a novel genetic player in nonalcoholic fatty liver and cardiovascular disease. Hepatol Commun. 2022;6(3):448\u201360.","journal-title":"Hepatol Commun"},{"issue":"6","key":"2196_CR27","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/hep.28142","volume":"62","author":"CJ Pirola","year":"2015","unstructured":"Pirola\u00a0CJ, Sookoian\u00a0S. The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis. Hepatology. 2015;62(6):1742\u201356.","journal-title":"Hepatology"},{"issue":"2","key":"2196_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12263-014-0388-4","volume":"9","author":"IA Stojkovic","year":"2014","unstructured":"Stojkovic\u00a0IA, et\u00a0al. The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels. Genes Nutr. 2014;9(2):388\u2013388.","journal-title":"Genes Nutr"},{"issue":"7","key":"2196_CR29","doi-asserted-by":"publisher","first-page":"e40376","DOI":"10.1371\/journal.pone.0040376","volume":"7","author":"NT Krarup","year":"2012","unstructured":"Krarup\u00a0NT, et al. The PNPLA3 rs738409 G\u2011allele associates with reduced fasting serum triglyceride and serum cholesterol in danes with impaired glucose regulation. PLoS ONE. 2012;7(7):e40376.","journal-title":"PLoS ONE"},{"issue":"3","key":"2196_CR30","first-page":"369","volume":"62","author":"M Krawczyk","year":"2011","unstructured":"Krawczyk\u00a0M, et\u00a0al. The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels. J\u00a0Physiol Pharmacol. 2011;62(3):369\u201375.","journal-title":"J Physiol Pharmacol"},{"issue":"11","key":"2196_CR31","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.2337\/db09-0279","volume":"58","author":"K Kantartzis","year":"2009","unstructured":"Kantartzis\u00a0K, et al. Dissociation between fatty liver and insulin resistance in humans carrying a\u00a0variant of the patatin-like phospholipase 3 gene. Diabetes. 2009;58(11):2616\u201323.","journal-title":"Diabetes"},{"issue":"4","key":"2196_CR32","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/hep.23622","volume":"51","author":"L Valenti","year":"2010","unstructured":"Valenti\u00a0L, et al. Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(4):1209\u201317.","journal-title":"Hepatology"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02196-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02196-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02196-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T11:11:33Z","timestamp":1715166693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02196-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":32,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02196-2","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"20 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.\u00a0Semmler, L.\u00a0Balcar, S.\u00a0Wernly, L.\u00a0Datz, M.\u00a0Semmler, L.\u00a0Rosenstatter, F.\u00a0Stickel, E.\u00a0Aigner, B.\u00a0Wernly and C.\u00a0Datz declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients provided written informed consent, and the study was approved by the local ethics committee (approval no. 415-E\/1262\/2-2010).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}